Serum markers of brain damage and outcome prediction in patients after severe head injury

British Journal of Neurosurgery

Volumn 13, Issue 1, 1999, Pages 56-59

  Raabe, Andreas ^a   Grolms, C ^b   Seifert, V ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

Head injury; Neuron specific enolase; Outcome; S 100 protein

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INJURY; ENZYME BLOOD LEVEL; FEMALE; HEAD INJURY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

EID: 0032992134     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688699944195     Document Type: Article

References (24)

1. 1 Grill M, Kunz WS, Huth C, Wallesch CW, Herrmann M. Specificity of NSE and S100B and release patterns in patients undergoing heart surgery. Pharmacopsychiatry 1998;31:(Abstract).
2. 2 Vollmer DG. Prognosis and outcome of severe head injury. In: Cooper PR, ed., Head Injury. Baltimore: Williams & Wilkins, 1993:553-81.
3. 3 Johnsson P. Markers of cerebral ischemia after cardiac surgery. J. Cardiothorac Vasc Anesth 1996;10:120-6.
4. 4 Ross SA, Cunningham RT, Johnston CF, Rowlands BJ. Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 1996;10:471-6.
5. 5 Johnsson P, Lundqvist C, Lindgren A, Ferencz I, Alling C, Stahl E. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. J Cardiothorac Vasc Anesth 1995;9:694-9.
6. 6 Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 1995;43:267-70.
7. 7 Hans P, Bonhomme V, Collette J, Moonen G. Neuron-specific enolase as a marker of in vitro neuronal damage. Part I: assessment of neuron-specific enolase as a quantitative and specific marker of neuronal damage. J Neurosurg Anesthesiol 1993;5:111-16.
8. 8 Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987;18:911-18.
9. 9 Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? [letter]. J Neurol Neurosurg Psychiatry 1995;59:103-4.
10. 10 Hu DN, McCormick SA, Ritch R. Isolation and culture of iris pigment epithelium from iridectomy specimens of eyes with and without exfoliation syndrome. Arch Ophthalmol 1997;115:89-94.
11. 11 Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 1996;27:1553-7.
12. 12 Fagnart OC, Sindic CJ, Laterre C. Particle counting immunoassay of S100 protein in serum. Possible relevance in tumours and ischemic disorders of the central nervous system. Clin Chem 1998;34:1387-91.
13. 13 Buttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 1997;28:1961-5.
14. 14 Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in cute ischemic stroke. Stroke 1997;28:1956-60.
15. 15 Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997;34:546-50.
16. 16 Westaby S, Johnsson P, Parry AJ, et al. Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 1996;61:88-92.
17. 17 Taggart DP, Mazel JW, Bhattacharya K, et al. Comparison of serum S-100 beta levels during CABG and intacardiac operations. Ann Thorac Surg 1997;63: 492-6.
18. 18 Astudillo R, van der Linden J, Radegran K, Hansson LO, Aberg B. Elevated serum levels of S-100 after deep hypothermic arrest correlate with duration of circulatory arrest. Eur J Cardiothorac Surg 1996;10:1107-13.
19. 19 Kramer MS. Clinical Epidemiology and Biostatistics. Berlin, Heidelberg, New York: Springer Verlag, 1988:204-8.
20. 20 Chambers IR, Mendelow AD. Receiver operator characteristic (ROC) curve analysis applied to CPP, ICP and outcome in severely head injured patients. In: Nagai H, et al., eds, Intracranial Pressure IX. Tokyo: Springer, 1994:64-7.
21. 21 Miliotes G, Lyman GH, Cruse CW, et al. Evaluation of new putative tumour markers for melanoma. Ann Surg Oncol 1996;3:558-63.
22. 22 von Schoultz E, Hansson LO, Djureen E, et al. Prognostic value of serum analyses of S-100 beta protein in malignant melanoma. Melanoma Res 1996;6:133-7.
23. 23 Guo HB, Stoffel Wagner B, Bierwirth T, Mezger J, Klingmuller D. Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 1995;31: 1898-902.
24. 24 Ingebrigsten T, Romner B. Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. Case report. J Neurosurg 1996;85:945-8.